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SUMMARY
The yeast EGO complex, consisting of Gtr1, Gtr2,
Ego1, and Ego3, localizes to the endosomal and
vacuolar membranes and plays a pivotal role in cell
growth and autophagy regulation through relaying
amino acid signals to activate TORC1. Here, we
report the crystal structures of a wild-type and a
mutant form of Saccharomyces cerevisiae Ego3.
Ego3 assumes a homodimeric structure similar to
that of the mammalian MP1-p14 heterodimer and
the C-terminal domains of the yeast Gtr1-Gtr2 heter-
odimer, both of which function in TORC1 signaling.
Structural and genetic data demonstrate that the
unique dimer conformation of Ego3 is essential for
the integrity and function of the EGO complex. Struc-
tural and functional data also identify a potential
binding site for Gtr1-Gtr2. These results suggest
a structural conservation of the protein components
involved in amino acid signaling to TORC1 and reveal
structural insights into the molecular mechanism of
Ego3 function in TORC1 signaling.
INTRODUCTION
The target of rapamycin (TOR) proteins are structurally and
functionally conserved from yeast to human and belong to the
phosphoinositide 3-kinase-related kinase family (Keith and
Schreiber, 1995). The mammalian TOR (mTOR) and its orthologs
are central regulators of cell growth, proliferation, and differenti-
ation, and have been implicated in many diseases including
cancers and diabetes. In all eukaryotes, TOR exists in two
distinct multiprotein complexes, TOR complex 1 (TORC1) and
TOR complex 2 (TORC2) (Kim et al., 2002; Loewith et al.,
2002). In yeast, TORC1 contains Tor1 or Tor2, Kog1, Lst8, and
Tco89 (Loewith et al., 2002; Reinke et al., 2004). TORC1 is
sensitive to growth factors, energy status, and amino acid supply
and functions as a regulator of transcription, protein translation,
ribosomal biogenesis, and autophagy (De Virgilio and Loewith,
2006; Guertin and Sabatini, 2007).
Amino acids are potent activators of TORC1 and stimulate
the phosphorylation of TORC1 substrates such as S6Ks and
4EBPs in mammals and Sch9 in yeast (Hara et al., 1998; Urban
et al., 2007). The conserved Rag GTPases integrate lysosomal
amino acid signals via the vacuolar ATPase (Zoncu et al.,
2011), and/or cytoplasmic leucine levels via the leucyl-tRNA
synthetase (Bonﬁls et al., 2012; Han et al., 2012), to control
TORC1 function (Binda et al., 2009; Dubouloz et al., 2005; Kim
et al., 2008; Sancak et al., 2008).
Mammalian cells contain four Rag GTPases, which form
heterodimers of either RagA or RagB with either RagC or RagD
(Schu¨rmann et al., 1995; Sekiguchi et al., 2001). Rag GTPases
do not directly stimulate the kinase activity of mTORC1 in vitro,
but regulate the intracellular localization of mTORC1 (Sancak
et al., 2008). Amino acid signals induce RagA/B to bind GTP,
and the corresponding heterodimers interact with Raptor and
mediate relocation of mTORC1 to Rab7-positive vesicles (late
endosomes and lysosomes) where mTORC1 can be activated
by the small GTPase Rheb (Sancak et al., 2008). No obvious lipid
modiﬁcation signals for membrane attachment have been found
in the amino acid sequences of Rag GTPases. Recently,
however, it was shown that the Ragulator complex consisting
of p18/LAMTOR1, p14/LAMTOR2, MP1/LAMTOR3, C7orf59/
LAMTOR4, and HBXIP/LAMTOR5, interacts with the Rag
GTPases and mediates mTORC1 translocation to lysosomal
membranes in response to amino acids (Sancak et al., 2010;
Bar-Peled et al., 2012). MP1 and p14 form an almost symmet-
rical heterodimer and are anchored to late endosomes or
lysosomes by p18 through its N-terminal lipidmodiﬁcation (Kurz-
bauer et al., 2004; Lunin et al., 2004; Nada et al., 2009; Sancak
et al., 2010).
Saccharomyces cerevisiae cells express a single Rag GTPase
heterodimer, namely, Gtr1-Gtr2, which forms, together with
Ego1/Meh1 and Ego3/Slm4, the EGO complex (EGOC) that
localizes to the vacuolar membrane (Dubouloz et al., 2005).
Depletion of any of the EGOC components leads to failure in
recovery from rapamycin-induced growth arrest and causes
low TORC1 activity, indicating that these proteins play an impor-
tant role in cell growth regulation upstream of TORC1 (Binda
et al., 2009; Dubouloz et al., 2005). In line with this assumption,
GTP-bound Gtr1 combines with GDP-bound Gtr2 to interact
with and activate TORC1 via a still elusive mechanism (Binda
et al., 2009). Analogous to the role of p18 in the Ragulator
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complex in higher eukaryotes, the N-myristoylated Ego1 may
serve to properly tether Gtr1-Gtr2 to the vacuolar/lysosomal
membrane for proper TORC1 activation (Ashraﬁ et al., 1998;
Kogan et al., 2010), while the role of Ego3 in this process is still
poorly understood.
In this study, we report the crystal structure of S. cerevisiae
Ego3, which signiﬁcantly differs from the previously published
Ego3 crystal structure that forms a dimer of dimers, or a tetramer
(Kogan et al., 2010). Notably, we show that Ego3 assumes
a homodimeric structure, which is very similar to both the
mammalian MP1-p14 heterodimer in the Ragulator complex
and the C-terminal domains of the yeast Gtr1-Gtr2 heterodimer.
In addition, structural and functional analyses of Ego3 and
Ego3 variants demonstrate that the unique dimer conformation
of Ego3 is essential for proper control of TORC1 activity.
RESULTS AND DISCUSSION
Overall Structure of the Ego3 Homodimer
The crystal structure of Ego3was solved using the single isomor-
phous replacement with anomalous scattering (SIRAS) method
with the anomalous scattering of I and reﬁned to 2.1 A˚ resolution
in space group C2221, yielding a Rwork of 17.3% and a Rfree of
22.1% (Table 1). There are two Ego3molecules in an asymmetric
unit forming a homodimer with a 2-fold noncrystallographic
symmetry (NCS) (Figure 1A), which is consistent with the results
of size-exclusion chromatography showing that Ego3 exists as
a homodimer in solution (Figure S1available online). The two
Ego3 monomers (hereafter designated as A and B) adopt an
almost identical overall structure with an rmsd of 0.6 A˚ for 152
Ca atoms. The full-length Ego3 consists of 162 residues with
a theoretical molecular mass of 18 kDa. The ﬁnal structure model
of the dimeric Ego3 contains the whole polypeptides except
the N-terminal residues 1–4 and the C-terminal 6xHis tag in
monomer A, and the N-terminal residues 1–4, residues 53–56
of a surface exposed loop, and the C-terminal 6xHis tag in
monomer B. Thus, monomer A with more detectable residues
is chosen for structural analysis and discussion unless otherwise
speciﬁed.
The Ego3 monomer consists of a central core b sheet of six
antiparallel b strands (b2-b1-b6-b5-b4-b3) ﬂanked by helix a2
on one side and helices a3 and a10 of the other monomer
(hereafter components of the other monomer are designated
by apostrophes) on the other side (Figure 1A). The Ego3 dimer
has two unique structural features: the core b sheets of the
two monomers are related by the 2-fold NCS to form an
extended 12 stranded antiparallel b sheet; the N-terminal helix
a1 of one monomer reaches over the other monomer via
a long a1/b1 loop to form a swapping conformation (Figure 1A).
A Unique Dimer Interface
The two Ego3 monomers in the asymmetric unit form a homo-
dimer. The dimer interface is formed mainly by helices a1 and
a3, the a1/b1 loop, and strands b1, b2, b3, and b6 of both mono-
mers, which involves 20 hydrogen bonds and numerous hydro-
phobic interactions (Table S1) and buries 2,092 A˚2 or 20.3%
of the total solvent accessible surface area as analyzed by
the PROTORP server (Reynolds et al., 2009). The interface is
composed of three regions (Figure 1B). In region I, the swapping
helix a10 of monomer B stretches into a hydrophobic groove
formed by helix a3 and strands b1, b2, and b6 of monomer A
and makes three hydrogen-bonding interactions and numerous
hydrophobic contacts with residues of monomer A (Figure 1B,
left panel; Table S1). With the 2-fold NCS of the homodimer,
the swapping helix a1 of monomer A has similar interactions
with the same structure elements of monomer B. In region II,
the N-terminal of helix a3 and the a1/b1 loop of one monomer
interact with the corresponding structure elements of the other
via eight hydrogen bonds and a number of hydrophobic
contacts, and vice versa (Figure 1B, middle panel; Table S1).
The a1/b1 loops of the two monomers contribute nearly one-
half of the hydrophilic interactions and one-third of the hydro-
phobic contacts at the dimer interface. Region III is formed
between theN termini of the two b3 strands of the twomonomers
via ﬁve hydrogen bonds and several hydrophobic contacts
Table 1. Summary of Diffraction Data and Structure Reﬁnement
Statistics
I-Derivative Wild-type M1 Mutant
Diffraction Data
Wavelength (A˚) 1.7712 0.9791 0.9794
Space group C2221 C2221 P43
Cell parameters
a (A˚) 61.52 61.96 60.53
b (A˚) 99.13 99.31 60.53
c (A˚) 158.58 156.11 116.85
Resolution (A˚) 50.0–2.70 50.0–2.10 50.0–2.60
(2.80–2.70)a (2.18–2.10) (2.69–2.60)
Observed reﬂections 89,071 135,634 58,777
Unique reﬂections (I/s(I) > 0) 13,889 28,959 12,915
Average redundancy 6.4 (4.4) 4.7 (4.1) 4.6 (4.5)
Average I/s(I) 21.9 (3.1) 17.1 (2.2) 15.5 (3.4)
Completeness (%) 98.8 (92.3) 99.5 (98.8) 99.7 (99.6)
Rmerge (%) 10.9 (44.6) 8.8 (44.4) 14.7 (43.1)
Reﬁnement and Structure Model
Reﬂections (FoR 0s(Fo))
Working set 27,380 12,218
Test set 1,448 649
Rwork/RFree (%/%) 17.3/22.1 20.8/25.2
No. of protein atoms 2,475 2,234
No. of water atoms 147 52
Average B factor (A˚2)
All atoms 53.0 47.1
Main chain 49.0 44.7
Side chain 56.7 47.4
Water 54.9 49.8
Rmsd
Bond lengths (A˚) 0.008 0.008




aNumbers in parentheses represent the highest resolution shell.











(Figure 1B, right panel; Table S1). In particular, Tyr96 contributes
more than half of the hydrophilic and hydrophobic contacts in
this region.
Sequence alignment of Ego3 from different species shows
that most of the residues of helices a1 and a3, and strands b1,
b2, b3, and b6 that are involved in the hydrophilic and hydro-
phobic contacts at the dimer interface are strictly or highly
conserved, including Val9, Phe12, Leu13, and Leu17 of helix
a1, Ser35 and Ile37 of strand b1, Ser47 and Tyr48 of strand b2,
Ser94, Cys95, and Tyr96 of strand b3, Leu129 of strand b6,
and Tyr139, Gly140, Leu141, and Lys145 of helix a3 (Figure S2A).
Although the residues of the a1/b1 loop are not conserved, the
lengths of the a1/b1 loop (12–15 residues) are comparable (Fig-
ure S2A). These conservations suggest that the homodimeric
architecture with a swapping conformation of Ego3 might exist
in other species and is essential for its biological function. In
particular, the a1/b1 loop appears to play a critical role in the
formation of the swapping conformation of the dimer and thus
might play an important role in Ego3 function.
Comparison of the Ego3 Dimer with Other Roadblock/
LC7 Domain-Containing Proteins
A structural similarity search in the Protein Data Bank using the
Dali server (Holm and Rosenstro¨m, 2010) reveals that Ego3
has a high structural similarity to members of the Roadblock/
LC7 superfamily (Koonin and Aravind, 2000). This family includes
the C-terminal domains of Gtr1 and Gtr2, MP1, p14, and the
recently discovered C7orf59/LAMTOR4 and HBXIP/LAMTOR5,
which all participate in TORC1 signaling (Cui et al., 2008; Gong
et al., 2011; Kurzbauer et al., 2004; Lunin et al., 2004; Sancak
et al., 2010; Bar-Peled et al., 2012) as well as a GTPase-
activating protein (GAP) MglB homodimer (Miertzschke et al.,
2011). For instance, superposition of Ego3 with MP1 and p14
in the MP1-p14 complex (PDB code 1VET) yields an rmsd of
Figure 1. Crystal Structure of the Ego3 Homodimer
(A) Ribbon representation of the Ego3 homodimer with monomer A in yellow and monomer B in cyan.
(B) Interactions at the Ego3 homodimer interface. Hydrogen bonds are indicated with dashed lines. Left panel: Interactions of the swapping helix a10 with residues
of monomer A. Middle panel: Interactions between helix a3 and the a1/b1 loop of the two monomers. Right panel: Interactions between the N-terminal part of
strand b3 of the two monomers.
(C) Ribbon representation of the Ego3-M1 homodimer with one monomer in pink and the other in light blue.











2.2 A˚ (80 Ca atoms) and 1.5 A˚ (84 Ca atoms), respectively. Inter-
estingly, detailed structural comparisons show that the Ego3 ho-
modimer has a similar architecture to the MP1-p14 heterodimer
(Kurzbauer et al., 2004; Lunin et al., 2004), the dimeric C-terminal
domains of the Gtr1-Gtr2 heterodimer (Gong et al., 2011), and
the MglB homodimer (Miertzschke et al., 2011) (Figure 2A).
Despite a low sequence similarity, MP1 and p14 adopt a nearly
identical overall structure and form an almost symmetrical heter-
odimer (Kurzbauer et al., 2004; Lunin et al., 2004); the same
holds true for the C-terminal domains of Gtr1 and Gtr2 (Gong
et al., 2011). Nevertheless, there are some notable differences
between the Ego3 homodimer and the MP1-p14 and Gtr1-Gtr2
heterodimers and the MglB homodimer. Speciﬁcally, Ego3 has
a swapping helix a1, a long a1/b1 loop (15 residues in Ego3, 4
residues in MP1, 5 residues in p14, 2 residues in Gtr1, 3 residues
in Gtr2, and 2 residues inMglB), an extra b strand (b3), and a bent
central b sheet (Figure S2B). These structural differences make
the Ego3 dimer adopt a twisted dimer conformation such that
the b3 strands of the two monomers have fewer interactions
with each other at the dimer interface, and the a2 helices of
the two monomers are positioned far apart without any interac-
tion (Figure 2A). However, the dimer interface of Ego3 is
augmented by the swapping of helix a1 and the following a1/
b1 loop and the interactions of the a3 helices of the two mono-
mers. Considering that the MP1-p14 heterodimer, the Gtr1-
Gtr2 heterodimer, and the MglB homodimer function as dimers,
the similarity of the dimeric architecture of Ego3 to these proteins
suggests that dimerization of Ego3 is essential for its biological
function.
Comparison of the Ego3 Dimer with the Ego3 Tetramer
Recently, a crystal structure of Ego3 was reported in which Ego3
forms a tetramer (PDB code 3LGO) (Kogan et al., 2010) (Fig-
ure 2B). Structural comparison shows that although the overall
structures of the Ego3 monomers in the homodimer and homo-
tetramer are very similar with an rmsd of 1.3 A˚ for about 112 Ca
atoms (superposition without the N-terminal helix a1 and the
following a1/b1 loop), the assemblies of the dimer and the
tetramer are signiﬁcantly different, particularly in the swapping
of helix a1 and the conformation of the a1/b1 loop region (Figures
2B and S3). In the structure of the Ego3 tetramer, an asymmetric
unit contains one monomer and four crystallographic symmetry-
related monomers form a dimer of dimers or a tetramer. The
dimeric interface between monomers A and B (or C and D)
involves largely hydrophobic interactions between strand b3
and helix a3 of each monomer and buries a total of 775 A˚
solvent-accessible surface areas (Figure S3A). This dimeric
interface is quite different from that in our Ego3 dimer: although
Figure 2. Structural Comparison of the Ego3 Dimer, the Other Road-
block/LC7 Domain-Containing Proteins, and the Ego3 Tetramer
(A) Ribbon representation of the Ego3 dimer and three Roadblock/LC7
domain-containing proteins, namely, the MP1-p14 heterodimer (PDB code
1VET), the MglB homodimer (PDB code 3T1S), and the C-terminal domains of
the Gtr1-Gtr2 heterodimer (PDB code 3R7W).
(B) Ribbon representation of the Ego3 tetramer (PDB code 3LGO). In a dimer,
one monomer is colored in green and the other in blue. Two adjacent dimers
associate with each other to form a tetramer. The nomenclature of the
secondary structures is after that by Kogan et al. (2010).











strand b3 and helix a3 are involved in formation of the dimeric
interface in both cases, the orientations of these structure
elements, the interaction modes, and the residues contributing
to the interactions are completely different (Figure S3A). If one
monomer is superimposed, the other would have a rotation of
116 relative to each other (Figure S3B). In the Ego3 dimer, the
N-terminal parts of strand b3 of the two monomers interact with
each other via several hydrogen bonds, leading to the formation
of an extended, intermolecular b sheet. In the Ego3 tetramer,
however, no hydrogen-bonding interactions exist between the
b3 strands of the two monomers and thus no continuous, inter-
molecular b sheet is formed. There is only one hydrogen bond
between the side chain of Tyr96 in strand b3 of monomer A and
the side chain of Arg148 in helixa3ofmonomerBat this interface.
As Arg148 is not conserved in different species (Figure S2A), the
signiﬁcance of this hydrogen-bonding interaction is not clear.
Moreover, the distance between the negatively charged side-
chain carboxyls of Glu99 of the two monomers is very close
(2.3 A˚) which may only be permitted by the special crystallization
condition of the Ego3 tetramer (Kogan et al., 2010). In the Ego3
tetramer, the tetrameric interface between the two dimers A/B
and C/D is mediated mainly through the a1/b1 loop region and
the swapping helix a1. The N-terminal helix a1 is swapped
between monomers A and C (and between monomers B and
D); the a1/b1 loop region forms a b strand which associates
with the equivalents of the other three monomers to form a four
stranded, orthogonal b sheet (Figure 2B). This is also quite
different from the Ego3 dimer in which the N-terminal helix a1 is
swapped between two adjacent monomers A and B, and the
long a1/b1 loop lies on the surface and connects helix a1 back
to its monomer. Thus, the question arises whether the Ego3
dimer or tetramer is the functional unit or is biologically relevant.
Biological Relevance of the Ego3 Dimer
To investigate the biological relevance of the Ego3 dimer and/or
tetramer, we ﬁrst examined the oligomeric state of Ego3 in solu-
tion using size-exclusion chromatography. Previously, Kogan
et al. reported that the equilibrium analytical ultracentrifugation
data suggested that Ego3 assumes a mixture of different oligo-
meric states; however, the size-exclusion chromatography
data showed that Ego3 attached with or without an N-terminal
6xHis tag exists in a single oligomeric state with a molecular
mass in the range of 25–43 kDa (Kogan et al., 2010). Consis-
tently, our size-exclusion chromatography data also showed
that the wild-type Ego3 exhibited a single peak with a molecular
mass in the range of 25–43 kDa (Figure S1). These results indi-
cate that Ego3 exists as a dimer rather than a tetramer or
a mixture of different oligomeric states in solution, which is in
agreement with our structural data. The discrepancy between
the equilibrium analytical ultracentrifugation and the size-
exclusion chromatography results by Kogan et al. is unclear.
The Ego3 protein has an N-terminal 6xHis tag in Kogan et al.,
but a C-terminal 6xHis tag in this study. In the structure of the
Ego3 tetramer, both the N and C termini of Ego3 are not involved
in dimer or tetramer formation. In the structure of the Ego3
dimer, the swapping N terminus is involved in interactions with
the other monomer but the C terminus is not involved in dimer
formation. Thus, the positions of the 6xHis tag should have no
effects on the formation of the dimer or the tetramer.
The crystals of the Ego3 tetramer were grown in a crystalli-
zation solution containing 200–350 mM L-arginine and at
a very low pH 3.0 (Kogan et al., 2010). L-arginine is often used
as a versatile solvent additive, which is helpful for protein refold-
ing and aggregation suppression. L-arginine at high concen-
tration (i.e., 1 M) can interact with the side chains of almost
all amino acids and can reduce hydrogen-bonding and ionic
interactions as well as hydrophobic interactions at protein-
protein interfaces (Arakawa et al., 2007). In addition, the pH value
can also have a great effect on protein-protein interactions.
At acidic pH conditions, some ionizable groups, such as the
side-chain hydroxyl of Tyr, would be protonated and more
hydrophobic. Thus, an acidic pH may induce conformational
changes of the tertiary structure by reduction of hydrophilic
interactions and/or introduction of hydrophobic interactions.
For example, an amidase from the hyperthermophilic archaeon
Sulfolobus solfataricus forms a dimer at pH above 8.0 but an
octamer at pH below 3.0 (D’Abusco et al., 2005). Thus, it appears
to be very likely that the formation of the Ego3 tetramer is an
artifact caused by the special crystallization condition, particu-
larly the high concentration of L-arginine and very acidic pH. In
other words, the Ego3 tetramer is unlikely to be biologically
relevant.
Additionally, as discussed above, structural comparison
shows that the Ego3 dimer has a similar architecture to the
MP1-p14 heterodimer and the C-terminal domains of the Gtr1-
Gtr2 heterodimer, both of which function as dimers in the
TORC1 signaling pathway. Furthermore, sequence comparison
shows that most of the residues involved in the formation of
the Ego3 dimer interface are strictly or highly conserved. Taken
all of these results together, we conclude that the Ego3 dimer
is the functional, biologically relevant unit.
Functional Importance of the Ego3 Dimer
To investigate whether the unique dimer conformation of Ego3
is required for its function, ﬁve mutants named Ego3-M0,
Ego3-M1, Ego3-M2, Ego3-M3, and Ego3-M8 were generated
(for details, see Table S2). Among these, Ego3-M1, Ego3-M3
and Ego3-M8 were selected for further analyses based on their
mislocalization and increased sensitivity to rapamycin treatment
in the initial characterization (Figures S4A and S4B). Basically, in
the Ego3-M1 mutant, the long a1/b1 loop is shortened such that
residues KPYDLHSVDFKTSSL are substituted with KPYGSL. A
conserved Tyr (Tyr96), located in strand b3, was found to be
involved in several hydrophilic and hydrophobic interactions in
region III of the dimeric interface. The Ego3-M3 variant contains
the same shortened a1/b1 loop as Ego3-M1 and additionally
a mutation of this speciﬁc Tyr to Glu (Y96E). Of note, the Y96E
mutation on its own (Ego3-M2) had no signiﬁcant impact on
Ego3-GFP localization or rapamycin-sensitivity of the corre-
sponding cells (Figure S4). Finally, in the Ego3-M8 mutant, the
N-terminal 17 residues including the swapping helix a1 are
deleted which was expected to prevent stable homodimer
formation.
Attempts to produce recombinant Ego3-M3 and Ego3-M8
proteins have remained unsuccessful (both were expressed as
inclusion bodies), thereby precluding further in vitro structural
analysis on these mutants. On the other hand, recombinant











oligomeric state in solution as judged from size-exclusion
chromatography analysis (Figure S1). We therefore went on to
determine the crystal structure of Ego3-M1.
The crystal structure of Ego3-M1 was solved using the molec-
ular replacement (MR) method and reﬁned to 2.6 A˚ resolution in
space group P43, yielding a Rwork of 20.8% and a Rfree of 25.2%
(Table 1). There are also two Ego3-M1 molecules in an asym-
metric unit forming a homodimer with a 2-fold NCS (Figure 1C).
Superposition of the two Ego3-M1 monomers yields an rmsd
of 0.2 A˚ for 139 Ca atoms. The ﬁnal structure model of the
Ego3-M1 dimer contains residues 6–156 of monomer A except
for residues 44–48 and 78–83, and residues 6–156 of monomer
B except for residues 44–48 and 80–82.
The Ego3-M1 monomer has an overall structure very similar
to that of the wild-type Ego3 monomer; however, the dimer
conformation of Ego3-M1 is signiﬁcantly different from that of
the wild-type Ego3 (Figures 1A and 1C). If we superpose one
monomer of the Ego3 and Ego3-M1 dimers, the other mono-
mer in the Ego3-M1 dimer has a rotation of 86 in relation to
that in the Ego3 dimer (Figure S5). Due to the shortening of
the a1/b1 loop, the two monomers rotate toward each other
along the axis vertical to the 2-fold NCS. Although the
N-terminal a1 helix in Ego3-M1 maintains a swapping con-
ﬁguration and has interactions with several structure elements
of the other monomer similar to that in the wild-type Ego3,
the two a1 helices and the side of the dimer where the a1/b1
loops are located, are pulled much closer to each other.
Concurrently, the central b sheets and the a2 helices of the
monomers rotate away from each other and are no longer inter-
acting. As a result, the two monomers are linked together
mainly by the swapping a1 helix and the a1/b1 loop of both
monomers and the dimer interface is much looser compared
to that in the wild-type Ego3. In other words, although Ego3-
M1 forms a dimer, the dimer interface is signiﬁcantly distorted,
altering its surface properties.
Next, we analyzed the capacities of the Ego3 variants to ho-
modimerize and bind to the other EGOC components in vivo
using the membrane-based split-ubiquitin two-hybrid system.
In line with our in vitro data, we found that Ego3-M1 could homo-
dimerize (Figure 3A). However, the presence of the additional
Y96E mutation in Ego3-M3 largely impaired its dimerization.
Absence of the swapping helix a1 also prevented dimerization
of Ego3-M8 (Figure 3A). Furthermore, regardless of whether
they could dimerize or not, these mutants failed to interact with
the vacuolar anchor Ego1 (Figure 3A), and consequently failed
to accumulate at the vacuolar periphery (Figure 3B). In addition,
all of these Ego3mutants failed to associate with theGTP-locked
forms of Gtr1 and Gtr2 (Figures 3A), which turned out to be the
best Ego3-interacting forms in the two-hybrid system (data not
shown). Moreover, Ego3-M3-GFP did not coprecipitate with
Gtr1-WT-TAP in pull-down experiment (Figure 3C). In parallel,
we examined the subcellular localization of Gtr1-WT-GFP in cells
expressing these ego3 mutants (Figure 3D). In cells expressing
the ego3-M1 mutant, Gtr1-WT-GFP could still concentrate at
the vacuolar membrane albeit to a lesser extent. In cells express-
ing the impaired dimerization mutants (ego3-M3 and ego3-M8),
like in ego3D cells, Gtr1-WT-GFP displayed a diffuse cyto-
plasmic staining (Figure 3D). Altogether, these results suggest
that dimerization of Ego3 is necessary but not sufﬁcient for asso-
ciation with its partners and localization to the vacuolar
membrane; instead, its unique dimer conformation and surface
properties matter.
Both abrogation of dimerization or alteration of the dimer
surface of Ego3 affect its capacity to interact with the other
EGOC components, and hence may affect proper EGOC-medi-
ated TORC1 signaling. To test this possibility, we compared the
abilities of the untagged Ego3 mutants to suppress the growth
defect and TORC1 activity defect of the ego3D strain (Figures
4A and 4B). While Ego3-M1 exhibited partial rapamycin sensi-
tivity compared to the other Ego3 variants tested, all of them
failed to recover from a 6 hr rapamycin treatment (Figure 4A).
Furthermore, leucine-starved cells responded less promptly
(Ego3-M1) or failed to respond to leucine restimulation (other
mutants) (Figure 4B), therefore conﬁrming the importance of
the unique dimer conformation of Ego3 for optimal EGOC-
mediated TORC1 activation.
A Potential Binding Site for Other Components
of the EGO Complex
Previous biological data have shown that Ego3 interacts with
Ego1 and Gtr1-Gtr2 to form the EGO complex (Dubouloz et al.,
2005; Gao and Kaiser, 2006). Our structural data in combination
with the mutagenesis data have further shown that the unique
dimer conformation of Ego3 is essential for its function and its
interactions with Ego1 and Gtr1-Gtr2. Thus, we were tempted
to identify potential binding site(s) for these protein partners on
Ego3. Sequence comparison shows that Ego3 is conserved in
different species (Figure S2A); the residues on the surface side
where helix a2 is located are more conserved than these on
the surface side where helix a1 and the a1/b1 loop are located,
and particularly, there are a number of strictly or highly
conserved residues in helix a2 and the b4/b5 loop on the same
side (Figure S6). We speculated that these conserved regions
might be potential binding site(s) for Ego1 and/or Gtr1-Gtr2,
and thus constructed several Ego3 mutants containing multiple
mutations in these regions including Ego3-M4, Ego3-M5,
Ego3-M6, and Ego3-M7 (for details, see Table S2 and Figure S6).
Ego3-M4 was the only one to show some rapamycin sensitivity
(Figure S4) and was therefore selected for further analyses
(Figures 3 and 4). Ego3-M4 harbors a quadruple mutation
(N67A/N68A/K70A/M71A) in the N-terminal part of helix a2.
Recombinant Ego3-M4 exhibited an unchanged oligomeric
state in solution (Figure S1). Consistent with this, Ego3-M4 was
able to homodimerize in two-hybrid assay (Figure 3A). It also
interacted with Ego1 (Figure 3A), and as expected, localized to
the vacuolar membrane (Figure 3B). However, it showed
reduced binding to Gtr2 (Figure 3A) and Gtr1 (Figures 3A and
3C). In agreement with this ﬁnding, Gtr1-WT-GFP was not re-
cruited to the vacuolar membrane in cells expressing Ego3-M4
(Figure 3D). Altogether, these results suggest that the N-terminal
region of helix a2 participates in the binding to Gtr1-Gtr2 and
the four mutations in Ego3-M4 impair its binding to the Gtr
GTPases.
Possible Functional Roles of Ego3 in TORC1 Activation
The EGO complex functions upstream of TORC1 signaling
(Binda et al., 2009). Loss of any of the EGOC components or











rapamycin-induced growth arrest (Binda et al., 2009; Dubouloz
et al., 2005). Recent studies have revealed the importance
of several scaffold proteins in mTORC1 signaling in mam-
malian cells: p18/LAMTOR1, p14/LAMTOR2, MP1/LAMTOR3,
C7orf59/LAMTOR4, and HBXIP/LAMTOR5 form an extended
Ragulator complex which, with the Rag GTPases, serves as
Figure 3. Ego3 Relies on Its Unique Dimer Conformation and Surface Properties to Interact with Its EGOC Partners and Localize to the
Vacuolar Membrane
(A) Interactions of the Ego3 variants (baits) with the sameEgo3 variants, or with Ego1,Gtr1-GTP, orGtr2-GTP (preys) were assessed using the split ubiquitin-based
membrane two-hybrid system (DualsystemsBiotech). For each combination tested, b-galactosidase activity is expressed inMiller units asmean±SD fromat least
three independent transformants grown overnight at 30C. Empty bait vector pCabWT and pDl2-Alg5 prey were used as negative controls. n.d., not determined.
(B) Localization of the wild-type and mutant Ego3-GFP. Left panel: Localization of Ego3-WT-GFP was examined in prototrophic ego1D ego3D gtr1D gtr2D cells
complemented for all the other EGOC components except the one indicated. Right panel: Localization of the Ego3-GFP variants was assayed in prototrophic
ego3D cells expressing the corresponding Ego3-GFP mutant protein.
(C) TAP pull-down assays were performed on lysates of cells expressing either untagged Gtr1-WT or Gtr1-WT-TAP together with the indicated mutant forms
of Ego3-GFP, Gtr2-WT-V5, and Ego1-GST. Coprecipitated proteins were eluted by TEV cleavage. Input and pulldown fractions were analyzed by western blot
and probed with the indicated antibodies.
(D) Localization of Gtr1-WT-GFP was examined in prototrophic ego3D cells expressing the indicated Ego3 variants.











a docking site for mTORC1 on lysosomal membrane (Sancak
et al., 2010; Bar-Peled et al., 2012). MP1 and p14 prefer to
form a heterodimer rather than homodimers (Lunin et al.,
2004). The high structural conservation between the MP1-p14
heterodimer and the Ego3 homodimer suggests that the Ego3
homodimer might be the counterpart of the MP1-p14 hetero-
dimer in yeast.
Based on our structural, biochemical and genetic data, we
propose that the unique homodimer conformation of Ego3 is
required for its binding to Ego1 and its recruitment to the vacu-
olar membrane. Moreover, the N-terminal region of its a2 helix
represents a binding site for Gtr1-Gtr2, and is critical for the
efﬁcient docking of the Gtr GTPases to the vacuolar anchor
Ego1. Interestingly, the extended form of the Ragulator complex
has recently been found to exhibit GEF activity toward the Rag
GTPases (Bar-Peled et al., 2012). We therefore suspect that,
besides having a scaffolding role within EGOC, Ego3 may also
work together with Ego1 and some other so-far-unidentiﬁed
proteins to fulﬁll a regulatory function in TORC1 activation.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Puriﬁcation of Proteins
The Ego3 open reading frame (ORF) was ampliﬁed by PCR from yeast genomic
DNA and inserted into the NcoI and XhoI restriction sites of the pET-28a
expression plasmid (Novagen) which attaches a 6xHis tag at the C terminus
Figure 4. Ego3 Relies on Its Unique Dimer
Conformation and Surface Properties to
Mediate Adequate TORC1 Signaling
(A) Prototrophic WT and ego3D strains expressing
the indicated Ego3 mutants were grown to expo-
nential phase. Serial 10-fold dilutions were spotted
on YPD supplemented with vehicle (veh.) or the
indicated concentrations of rapamycin. Alterna-
tively, they were treated for 6 hr with 200 ng/ml
rapamycin, washed twice, and spotted on YPD
(Rap recovery).
(B) In vivo TORC1 activity was assessed by
monitoring the phosphorylation level of the TORC1
substrate Sch9 in the indicated leucine auxotro-
phic strains grown to exponential phase, starved
for leucine for 90min and restimulated with leucine
(2.8 mM) for the indicated times. Numbers below
represent TORC1 activity in either exponentially
growing cells or cells restimulated with leucine for
25 min. WT TORC1 activity was set to 1 in each
condition tested.
See also Tables S2–S4 and Figures S4 and S6.
of the target protein. The plasmid was transformed
into the Escherichia coli BL21 (DE3) strain. The
transformed cells were grown at 37C in lysogeny
broth medium containing 0.05 mg/ml kanamycin
until OD600 reached 0.8, and then induced with
0.5 mM isopropyl b-D-1-thiogalactopyranoside
at 20C for 20 hr. Cells were harvested and
lysed by sonication in lysis buffer (30 mM Tris-
HCl [pH 7.5] and 200 mM NaCl). 6xHis-tagged
Ego3 was puriﬁed by afﬁnity chromatography
using a Ni-NTA column (QIAGEN) with the lysis
buffer supplemented with 30 mM imidazole and
200 mM imidazole serving as washing buffer and
elution buffer, respectively. The elution sample was further puriﬁed by gel
ﬁltration using a Superdex 75 10/300 (preparative grade) column (GE Health-
care) preequilibrated with storage buffer (10 mM HEPES [pH 7.5], 100 mM
NaCl, 2 mMMgCl2, and 1 mM DTT). The target protein was of sufﬁcient purity
(>95%) as determined by SDS-PAGE (12% gel).
Constructs of the ego3 mutants containing point mutations, deletions, or
substitutions were generated using the QuikChange Site-Directed Mutagen-
esis Kit (Strategene) or the TakaRa MutanBEST Mutagenesis Kit (TaKaRa
Biotechnology) following the instructionmanuals. Designs of the Ego3mutants
are summarized in Table S2. Expression and puriﬁcation of the Ego3 mutants
were performed as for the wild-type protein.
For construction of pRS414-GTR2p-GTR2-WT-V5-6HIS, the GTR2 pro-
moter and ORF without a stop codon were ampliﬁed by PCR from yeast
genomic DNA and cloned in frame as a XhoI-BamHI fragment together with
a BamHI-NotI PCR fragment encoding V5-6HIS-CYC1 terminator into
pRS414 digested with XhoI-NotI.
Crystallization, Data Collection, and Structure Determination
Crystallization of the wild-type Ego3 and the Ego3-M1 mutant was performed
using the hanging drop vapor diffusion method by mixing 1.5 ml protein
solution (about 15 mg/ml) and 1.5 ml reservoir solution at 4C. Crystals of
Ego3 were grown from drops consisting of a reservoir solution of 35%
tacsimate (pH 7.0) after about 1 week. I-derivatized crystals were prepared
by soaking the crystals of Ego3 in the crystallization solution containing 1 M
NaI for 60 s. Crystals of Ego3-M1 were obtained from drops consisting of
a reservoir solution of 1.6 M ammonium sulfate, 0.1 M MES monohydrate
(pH 6.5), and 10% 1,4-dioxane. Single-wavelength anomalous dispersion
diffraction data were collected to 2.7 A˚ resolution from a ﬂash-cooled I-deriv-











to 2.1 and 2.6 A˚ resolution, respectively, at 175C at beamline 17U of
Shanghai Synchrotron Radiation Facility (SSRF), China. The diffraction data
were processed, integrated, and scaled together with HKL2000 (Otwinowski
and Minor, 1997). The statistics of the diffraction data are summarized in
Table 1.
The structure of Ego3 was solved using the SIRAS method implemented in
Phenix (Adams et al., 2010). An initial model of 312 out of 324 residues of two
Ego3 molecules and 131 water molecules was constructed automatically by
ARP/wARP in warpNtrace mode (Perrakis et al., 1999). The remaining residues
and additional water molecules were built manually using Coot (Emsley and
Cowtan, 2004). The structure of Ego3-M1 was solved by the MR method
implemented in Phenix. Structure reﬁnement was carried out using Phenix
and Refmac5 (Adams et al., 2010; Murshudov et al., 1997). The stereochem-
istry of the protein models was analyzed using MolProbity (Davis et al.,
2007). Structure analysis was carried out using programs in CCP4 (Winn
et al., 2011). The ﬁgures were generated using Pymol (http://www.pymol.
org). The statistics of the structure reﬁnement and the quality of the ﬁnal
structure models are summarized in Table 1.
Plasmids, Strains, and Growth Conditions
Plasmids used in this study are listed in Table S3. Cloning and site-directed
mutagenesis were carried out following standard procedures. All constructs
were veriﬁed by sequencing. Functionality of endogenously expressed
untagged and tagged EGOC fusion proteins was conﬁrmed by rapamycin
sensitivity, recovery from rapamycin-induced growth arrest, and TORC1
activity assays.
S. cerevisiae strains used in this study are listed in Table S4. Prototrophic
strains were used unless otherwise speciﬁed. Strains were grown to ex-
ponential phase at 30C in synthetic deﬁned medium with 2% glucose
complemented with the appropriate nutrients for plasmid maintenance.
When indicated (Rap recovery), they were treated with 200 ng/ml rapamycin
for 6 hr at 30C, washed twice, and serial 10-fold dilutions were spotted on
complete rich medium (YPD). For microscopy studies, exponentially growing
cells were analyzed as described previously (Talarek et al., 2010).
Sch9 Phosphorylation Analyses
Sch9T570A-HA5 C-terminal phosphorylation was monitored following 2-Nitro-
5-thiocyanatobenzoic acid -induced chemical cleavage as described previ-
ously (Urban et al., 2007; Wanke et al., 2008). To assess TORC1 activity
upon leucine refeeding, leucine auxotrophs were starved for leucine for
90 min prior to leucine (2.8 mM) readdition for the indicated times. Quantiﬁca-
tion of TORC1 activity (extent of Sch9 phosphorylation) was determined as
previously described in (Binda et al., 2009) and the TORC1 activity for Ego3-
WT was set to 1.
Coimmunoprecipitation Experiments
Lysates from cells expressing untagged Gtr1-WT (Gtr1-WT) or Gtr1-WT-TAP
and the other indicated EGOC fusion proteins were incubated with IgG-coated
Sepharose beads (GE Healthcare). Pulled-down proteins were released by
Tobacco Etch Virus (TEV) protease cleavage overnight at 4C, precipitated
with TCA/acetone, and resolved on 9% gel. Anti-TAP (Open Biosystems),
anti-V5 (Invitrogen), anti-GFP (Roche), and anti-GST (Santa Cruz) antibodies
along with mouse or rabbit light-chain-speciﬁc HRP-conjugated antibodies
(Jackson ImmunoResearch) were used to detect Gtr1-WT-TAP, Gtr2-WT-
V5, Ego3-GFP, and Ego1-GST, respectively.
ACCESSION NUMBERS
The crystal structures of the wild-type Ego3 and the Ego3-M1 mutant have
been deposited with the Protein Data Bank under accession codes 4FTX
and 4FUW, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four tables and six ﬁgures and can be
found with this article.
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Table S1. Hydrogen bonds and van der Waals contacts at the dimer interface of
the Ego3 homodimer
(A) Hydrogen bonds
Monomer A Location Distance (Å) Monomer B Location
Lys10-N] D1 2.8 Tyr48-O E2’
Thr16-OJ1 D1 2.8 Ser35-OJ E1’
Leu17-O D1 3.4 Leu32-N D1’/E1’ loop
Pro19-N D1/E1 loop 3.5 Ser31-OJ D1’/E1’ loop
Tyr20-N D1/E1 loop 2.9 Ser30-O D1’/E1’ loop
Asp26-O D1/E1 loop 2.8 Arg148-NK1 D3’
Asp26-O D1/E1 loop 2.9 Arg148-NK2 D3’
Ser30-O D1/E1 loop 3.0 Tyr20-N D1’/E1’ loop
Ser31-OJ D1/E1 loop 3.4 Pro19-N D1’/E1’ loop
Ser35-OJ E1 2.8 Thr16-OJ1 D1’
Tyr48-O E2 3.0 Lys10-N] D1’
Asn93-O E3 2.9 Cys95-N E3’
Ser94-OJ E3 2.8 Tyr96-OK E3’
Cys95-N E3 2.8 Asn93-O E3’
Tyr96-OK E3 3.6 Tyr96-OK E3’
Tyr96-OK E3 2.8 Ser94-OJ E3’
Lys145-N] D3 2.9 Thr16-O D1’
Arg148-NK1 D3 2.7 Asp26-O D1’/E1’ loop
Arg148-NK2 D3 3.1 Asp26-O D1’/E1’ loop
Glu152-OG1 D3 3.4 His5-NG1 N-terminal
(B) van der Waals contacts a ( 4.0 Å)
Monomer A Location Monomer B Location
Val9 (4) D1 Ile37 (1) E1’
Ser47 (2) E2’
Leu156 (1) D3’
Lys10 (5) D1 Ser47 (2) E2’
Tyr48 (3) E2’
Phe12 (11) D1 Ala149 (3) D3’
Glu152 (2) D3’
Leu153 (6) D3’

















Glu14 (6) D1 Ala49 (6) D2’
Thr16 (10) D1 Leu32 (4) D1’/E1’ loop
Ser35 (2) E1’
Lys145 (4) D3’







Pro19 (6) D1/E1 loop Ser30 (2) D1’/E1’ loop
Ser31 (4) D1’/E1’ loop




Leu22 (7) D1/E1 loop Leu22 (6) D1’/E1’ loop
Leu141 (1) D3’
His23 (4) D1/E1 loop His23 (4) D1’/E1’ loop
Asp26 (3) D1/E1 loop Arg148 (3) D3’
Phe27 (2) D1/E1 loop Arg148 (2) D3’
Ser30 (7) D1/E1 loop Pro19 (2) D1’/E1’ loop
Tyr20 (5) D1’/E1’ loop
Ser31 (7) D1/E1 loop Leu17 (3) D1’
Lys18 (1) D1’/E1’ loop
Pro19 (3) D1’/E1’ loop
Leu32 (7) D1/E1 loop Thr16 (5) D1’
Leu17 (2) D1’
Ser34 (2) E1 Leu17 (2) D1’
Ser35 (7) E1 Leu13 (3) D1’
Thr16 (2) D1’
Leu17 (2) D1’
Met36 (1) E1 Leu13 (1) D1’
Ile37 (2) E1 Val9 (1) D1’
Leu13 (1) D1’
Ser47 (7) E2 Val9 (1) D1’
Lys10 (2) D1’
Leu13 (4) D1’












Ala49 (10) E2 Leu13 (3) D1’
Glu14 (4) D1’
Leu17 (3) D1’
Thr50 (4) E2 Leu17 (4) D1’
Ser51 (1) E2/D2 loop Leu17 (1) D1’
Thr87 (2) D2/E3 loop Glu89 (2) D2’/E3’ loop
Glu88 (3) D2/E3 loop Glu89 (2) D2’/E3’ loop
Asn93 (9) E3 Ser94 (3) E3’
Cys95 (4) E3’
Tyr96 (2) E3’
Ser94 (12) E3 Asn93 (3) E3’
Ser94 (4) E3’
Tyr96 (5) E3’
Cys95 (5) E3 Asn93 (5) E3’





Thr109 (2) E4 Tyr96 (2) E3’
Leu129 (1) E6 Leu13 (1) D1’
Phe131 (2) E6 Thr16 (2) D1’
Tyr139 (7) D3 Tyr96 (7) E3’
Gly140 (7) D3 Gly140 (6) D3’
Ile144 (1) D3’
Leu141 (5) D3 Tyr20 (2) D1’/E1’ loop
Leu22 (1) D1’/E1’ loop
Ile144 (2) D3’
Val143 (1) D3 Tyr96 (1) E3’
Ile144 (4) D3 Tyr20 (1) D1’/E1’ loop
Gly140 (1) D3’
Leu141 (2) D3’
Lys145 (10) D3 Thr16 (3) D1’
Tyr20 (8) D1’/E1’ loop
Arg148 (7) D3 Tyr20 (1) D1’/E1’ loop
Val25 (2) D1’/E1’ loop
Asp26 (2) D1’/E1’ loop
Phe27 (2) D1’/E1’ loop
Ala149 (3) D3 Phe12 (3) D1’
Glu152 (1) D3 Phe12 (1) D1’
Leu153 (5) D3 Phe12 (5) D1’
a There are a total of 264 van der Waals contacts. Number in parentheses refers to the 











Table S2. Design of the Ego3 mutants
Mutant Mutation Location
M0 Substitution of KPYDLHSVDFKTSSL with
KPYGSTSSL
D1/E1 loop








M7 E111A/E113A/D114A E4/E5 loop











Table S3. Plasmids used in this study
Plasmid Description Source Figure
pRS413 CEN, HIS3 Ref. 1 3D; 4A-B; S4B-C
pRS414 CEN, TRP1 Ref. 1 3B; 3D; 4A-B;
S4A-C
pRS415 CEN, LEU2 Ref. 1 3B; 4A; S4A-C
pRS416 CEN, URA3 Ref. 1 3B; 3D; 4A; 
S4A-B
pMPG2180 pRS413-EGO3p-EGO3-WT-GFP This study 3B-C; S4A-C
YCplac33 CEN, URA3 Ref. 2
pMPG2181 pRS413-EGO3p-EGO3-M0-GFP This study S4A-C
pMPG2182 pRS413-EGO3p-EGO3-M1-GFP This study 3B; S4A-C
pMPG2188 pRS413-EGO3p-EGO3-M2-GFP This study S4A-C
pMPG2183 pRS413-EGO3p-EGO3-M3-GFP This study 3B-C; S4A-C
pMPG2184 pRS413-EGO3p-EGO3-M4-GFP This study 3B-C; S4A-C
pMPG2185 pRS413-EGO3p-EGO3-M5-GFP This study S4A-C
pMPG2189 pRS413-EGO3p-EGO3-M6-GFP This study S4A-C
pMPG2186 pRS413-EGO3p-EGO3-M7-GFP This study S4A-C
pMPG2270 pRS413-EGO3p-EGO3-M8-GFP This study 3B; S4A-C
pMPG2030 YCpLac33-EGO1p-EGO1-GST swapped to 
LEU2
This study 3B-C
pJU650 pRS416-GTR1p-GTR1-WT This study 3C
pMB1344 YCpLac33-GTR1p-GTR1-WT-TAP Ref. 3 3B-C
pMPG2177 pRS414-GTR2p-GTR2-WT-V5-6HIS This study 3B-C
pJU1030 pRS416-SCH9p-SCH9T570A-HA5 Ref. 4 4A-B; S4C
pMPG2280 pRS413-EGO3p-EGO3-WT This study 3D; 4A-B
pMPG2298 pRS413-EGO3p-EGO3-M1 This study 3D; 4A-B
pMPG2279 pRS413-EGO3p-EGO3-M3 This study 3D; 4A-B
pMPG2261 pRS413-EGO3p-EGO3-M4 This study 3D; 4A-B
pMPG2271 pRS413-EGO3p-EGO3-M8 This study 3D; 4A-B
p1559 pDL2-Alg5 Dualsystems 3A
p1571 pCabWT Dualsystems 3A
pMPG2220 pCabWT-EGO3-WT This study 3A
pMPG2265 pCabWT-EGO3-M1 This study 3A
pMPG2267 pCabWT-EGO3-M3 This study 3A
pMPG2268 pCabWT-EGO3-M4 This study 3A












pMPG2221 pPR3-N-EGO3-WT This study 3A
pMPG2255 pPR3-N-EGO3-M1 This study 3A
pMPG2257 pPR3-N-EGO3-M3 This study 3A
pMPG2258 pPR3-N-EGO3-M4 This study 3A
pMPG2259 pPR3-N-EGO3-M8 This study 3A
pNP1696 pPR3-N-EGO1 Ref. 3 3A
pNP1691 pPR3-N-GTR1-Q65L (GTP) Ref. 3 3A











Table S4. S. cerevisiae strains used in this study
Strain Genotype Source Figure
KT1960 MATD his3 leu2 ura3 trp1 Ref. 4
KT1961 MATa his3 leu2 ura3 trp1 Ref. 4 4A-B; 
S1B-C 






MPG2963 MATa LEU2::GTR1-WT-GFP ego3¨.DQ0;
gtr1¨QDW0;KLVXUD-52 leu2 trp1
This study 3D
NMY51 MATa his3¨WUS-901 leu2-3,112 ade2 
LYS::(lexAop)4-HIS3 ura3::(lexAop)8- lacZ 
ade2::(lexAop)8-ADE2 GAL4
Dualsystems
MPG2952 MATa ego3¨.DQ0;his3¨WUS-901 
leu2-3,112 ade2 LYS::(lexAop)4-HIS3 















Figure S1. Analyses of the oligomeric states of the wild-type and Ego3 mutants in 
solution by size-exclusion chromatography. Absorbance at 280 nm is plotted against 
the elution volume. Positions of the molecular mass standards are indicated. The 
curves for Ego3-WT, Ego3-M0, Ego3-M1, and Ego3-M4 are colored in red, blue, 
pink, and green, respectively.
Figure S2. Sequence comparison of Ego3 from different species and with several
Roadblock/LC7 domain containing proteins. (A) Sequence alignment of Ego3 from 
different species. The sequences include Saccharomyces cerevisiae, Lachancea 
thermotolerans, Vanderwaltozyma polyspora, Zygosaccharomyces rouxii, Ashbya
gossypii, and Candida glabrata. The secondary structures of S. cerevisiae Ego3 are 
placed above the alignment. Tyr96 and Arg148 that are involved in the dimer 
interface are indicated with a star and a triangle, respectively. The sequence 
alignments were performed using the program ESPript (Ref. 5). The secondary 
structures of S. cerevisiae Ego3 were also determined by ESPript. (B) Structure-based 
sequence alignment of Ego3 with several Roadblock/LC7 domain containing proteins.
The secondary structures of Ego3 are placed above the alignment and those of p14 are 
placed below the alignment. The residues in the D1/E1 loop are underlined. The 
sequence alignments were performed using the program ESPript.
Figure S3. Structural comparison of the dimeric interface in the Ego3 dimer and the 
Ego3 tetramer. (A) Ribbon representation of the Ego3 tetramer, which is colored with 
monomers A and C in green and monomers B and D in blue, respectively. The 
zoom-in window shows the interactions between the twoE3 strands of monomers A
and B. Hydrogen bonds are indicated with dashed lines. (B) Superposition of the 
Ego3 homodimer and the A/B dimer in the Ego3 homotetramer. The Ego3 homodimer 
is colored with one monomer in yellow and the other in cyan; monomers A and B in 
the Ego3 homotetramer are colored in green and blue, respectively. When one 












Figure S4. Initial characterization of the ego3 mutants. (A) Subcellular localization of 
the Ego3-GFP variants. (B) Response of the ego3 mutants to rapamycin treatment. 
Serial 10-fold dilutions were spotted on complete rich medium (YPD) supplemented 
with vehicle (veh.) or the indicated concentrations of rapamycin. Alternatively, they 
were treated for 6 hrs with 200 ng/ml rapamycin, washed twice, spotted on YPD (Rap 
recovery), and grown for 2 days at 30°C. (C) TORC1 activity in exponentially 
growing ego3 mutants. In vivo TORC1 activity was assessed by monitoring the 
phosphorylation level of the TORC1 substrate Sch9 in the indicated prototrophic 
strains. Numbers below represent TORC1 activity in exponentially growing cells. 
TORC1 activity in ego3' cells expressing Ego3-WT-GFP served as a reference and 
was set to 1.
Figure S5. Structural comparison of Ego3-WT and Ego3-M1. The color coding of the 
monomers is the same as in Figure 1. When one monomer is superimposed, the other 
in the Ego3-M1 dimer rotates ~86° relative to that in the Ego3-WT dimer.
Figure S6. Distribution of the conserved residues on the surface of the Ego3 dimer. 
The strictly conserved, conserved, and less conserved residues are colored in orange, 
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